A topology perspective on macrophages in melanoma metastasis
- PMID: 35584636
- PMCID: PMC9254629
- DOI: 10.1016/j.xcrm.2022.100643
A topology perspective on macrophages in melanoma metastasis
Abstract
In this issue of Cell Reports Medicine, Martinek et al.1 provide a window into the regional specialization of macrophages infiltrating metastatic melanoma. Combining histo-cytometry and transcriptomics, they identify a signature of stromal macrophages with dendritic cell features and clinical relevance.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests A.M. reports personal fees over the last 10 years from Ventana, Pierre Fabre, Verily, AbbVie, Astra Zeneca, Myeloid Therapeutics, Third Rock Venture, Imcheck Therapeutics, Ellipses, Novartis, Roche, Macrophage Pharma, BiovelocIta, Merck, Olatec, Principia; royalties from sale of reagents from Cedarlane Laboratories Ltd, HyCult Biotechnology, eBioscience, BioLegend, Abcam Plc, Novus Biologicals, Enzo Life, and Affymetrix, outside the submitted work. In addition, A.M. is inventor of patents related to cellular and humoral innate immunity.
Figures

Comment on
-
Transcriptional profiling of macrophages in situ in metastatic melanoma reveals localization-dependent phenotypes and function.Cell Rep Med. 2022 May 17;3(5):100621. doi: 10.1016/j.xcrm.2022.100621. Epub 2022 Apr 27. Cell Rep Med. 2022. PMID: 35584631 Free PMC article.
References
-
- Martinek J., Lin J., Kim K.I., Wang V.G., Wu T.-C., Chiorazzi M., Boruchov H., Gulati A., Seeniraj S., Sun L., et al. Transcriptional profiling of macrophages in situ in metastatic melanoma reveals localization-dependent phenotypes and function. Cell Rep. Med. 2022;3:100621-1–100621-15. - PMC - PubMed